Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 650-653

  Iłz̈ecka, Joanna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amyotrophic lateral sclerosis; Granzyme A; Granzyme B; Neurodegeneration; Pathomechanisms; Serum

Indexed keywords

GRANZYME A; GRANZYME B;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GRANZYMES; HUMANS; MALE; MIDDLE AGED;

EID: 79955803720     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.02.006     Document Type: Article

References (49)

1. Sathasivam S., Ince P.G., Shaw P.J. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol 2001, 27:257-274.
2. Wenqenack T.M., Holasek S.S., Montano C.M., Gregor D., Curran G.L., Poduslo J.F. Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model. Brain Res 2004, 1027:73-86.
3. Häggström B., Andersen P.M., Hjalmarsson K., Binzer M., Forsgren L. Autoimmunity and ALS: studies on antibodies to acetylcholinesterase in sera. Acta Neurol Scand 1997, 95(2):111-114.
4. Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992, 140(3):691-707.
5. McGeer P.L., McGeer E.G. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 2004, 1035:104-116.
6. Engelhardt J.I., Tajiti J., Appel S.H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol 1993, 50(1):30-36.
7. Chiu I.M., Chen A., Zheng Y., et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci USA 2008, 105:17913-17918.
8. Holmøy T. T cells in amyotrophic lateral sclerosis. Eur J Neurol 2008, 15:360-366.
9. Mosley R.L., Gendelman H.E. Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders. Exp Neurol 2010, 222:1-5.
10. Chowdhury D., Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 2008, 26:389-420.
11. Prakash M.D., Bird C.H., Bird P.I. Active and zymogen forms of granzyme B are constitutively released from cytotoxic lymphocytes in the absence of target cell engagement. Immunol Cell Biol 2009, 87:249-254.
12. Bovenschen N., Kummer J.A. Orphan granzymes find a home. Immunol Rev 2010, 235:117-127.
13. Bunnett N.W. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost 2006, 32(Suppl 1):39-48.
14. Shpacovitch V., Feld M., Bunnett N.W., Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007, 28:541-550.
15. Ashton-Rickardt P.G. The granule pathway of programmed cell death. Crit Rev Immunol 2005, 25(3):161-182.
16. Hendel A., Hiebert P.R., Boivin W.A., Williams S.J., Granville D.J. Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ 2010, 17:596-606.
17. Buzza M.S., Bird P.I. Extracellular granzymes: current perspectives. Biol Chem 2006, 387:827-837.
18. Suidan H.S., Bouvier J., Schaerer E., Stone S.R., Monard D., Tschopp J. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc Natl Acad Sci USA 1994, 91(17):8112-8116.
19. Ebnet K., Hausmann M., Lehmann-Grube F., et al. Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J 1995, 14(17):4230-4239.
20. Matkar S.S., Menaa C., Pardo J., et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 2008, 29(5):720-733.
21. Waterhouse N.J., Sedelies K.A., Browne K.A., Wowk M.E., Newbold A., Sutton V.R., et al. A central role for Bid in granzyme B-induced apoptosis. J Biol Chem 2005, 280(6):4476-4482.
22. Boivin W.A., Cooper D.M., Hiebert P.R., Granville D.J. Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest 2009, 89(11):1195-1220.
23. Kam C.M., Hudig D., Powers J.C. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000, 1477(1-2):307-323.
24. Brooks B.R. El Escorial Word Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994, 124(Suppl):96-107.
25. Gordon P.H., Miller R.G., Moore D.H. ALSFRS-R. Amyotroph Lateral Scler Other Mot Neuron Disord 2004, 5:90-93.
26. Stanisz A. Przyste{ogonek}pny kurs statystyki 1998, StatSoft Polska, Kraków.
27. Anthony D.A., Andrews D.M., Watt S.V., Trapani J.A., Smyth M.J. Functional dissection of the granzyme family: cell death and inflammation. Immunol Rev 2010, 235:73-92.
28. Galimberti D., Fenoglio C., Scarpini E. Inflammation in neurodegenerative disorders; friend or foe?. Curr Aging Sci 2008, 1:30-41.
29. Almer G., Guégan C., Teisman P., et al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001, 49:176-185.
30. Zhou F. Expression of multiple granzymes by cytotoxic T lymphocyte implies that they activate diverse apoptotic pathways in target cells. Int Rev Immunol 2010, 29(1):38-55.
31. Bien C.G., Bauer J., Deckwerth T.L., et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002, 51(3):311-318.
32. Bauer J., Bien C.G., Lassmann H. Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes. Curr Opin Neurol 2002, 15(2):197-200.
33. Bauer J., Elger C.E., Hans V.H., Schramm J., Urbach H., Lassmann H., et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007, 62(1):67-80.
34. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull 2009, 80:224-232.
35. Takahashi Y., Mine J., Kubota Y., Yamazaki E., Fujiwara T. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells TNFalpha, and Granzyme B in CSF. Epilepsia 2009, 50(6):1419-1431.
36. Gelpi E., Preusser M., Laggner U., Garzuly F., Holzmann H., Heinz F.X., et al. Inflammatory response in human tick-borne encephalitis: analysis of postmortem brain tissue. J Neurovirol 2006, 12(4):322-327.
37. Henkel J.S., Beers D.R., Zhao W., Appel S.H. Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol 2009, 4:389-398.
38. Kebir H., Kreymborg K., Ifergan I., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13(10):1173-1175.
39. Malmestrom C., Lycke J., Haghighi S., Andersen O., Carlson L., Wandevik H., et al. Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. J Neuroimmunol 2008, 196(1-2):159-165.
40. Gobel K., Melzer N., Herrmann A.M., et al. Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack. Glia 2010, 58(4):469-480.
41. Kroner A., Ip C.W., Thalhammer J., Nave K.A., Martini R. Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice. Am J Pathol 2010, 176(2):549-555.
42. Jaarsma D., Teuling E., Haasdijk E.D., De Zeeuw C.I., Hoogenraad C.C. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J Neurosci 2008, 28:2075-2088.
43. Casciola-Rosen L., Miagkov A., Nagraju K., et al. Granzyme B: evidence for a role in the origin of myasthenia gravis. J Neuroimmunol 2008, 201-202:33-40.
44. Niebroj-Dobosz I., Dziewulska D., Janik P. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS). Folia Neuropathol 2006, 44:191-196.
45. Chaitanya G.V., Kolli M., Babu P.P. Granzyme-b mediated cell death in the spinal cord-injured rat model. Neuropathology 2009, 29(3):270-279.
46. Skjelland M., Michelsen A.E., Krohg-Sorensen K., et al. Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis 2007, 195(2):142-146.
47. Chaitanya G.V., Schwaninger M., Alexander J.S., Babu P.P. Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience 2010, 165(4):1203-1216.
48. Lakhan S.E., Kirchgessner A., Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009, 7:97.
49. Block M.L., Calderón-Garideñas L. Air pollution: mechanisms of neuroinflammation and CNS disease. Trends Neurosci 2009, 32:506-516.